Jayson D.A. Dallas
2018
In 2018, Jayson D.A. Dallas earned a total compensation of $9.2M as Chief Executive Officer at Aimmune Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $337,000 |
|---|---|
| Option Awards | $6,781,145 |
| Salary | $287,562 |
| Stock Awards | $1,840,800 |
| Total | $9,246,507 |
Dallas received $6.8M in option awards, accounting for 73% of the total pay in 2018.
Dallas also received $337K in non-equity incentive plan, $287.6K in salary and $1.8M in stock awards.
Rankings
In 2018, Jayson D.A. Dallas' compensation ranked 793rd out of 14,244 executives tracked by ExecPay. In other words, Dallas earned more than 94.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 793 out of 14,244 | 94th |
Division Manufacturing | 264 out of 5,759 | 95th |
Major group Chemicals And Allied Products | 78 out of 2,122 | 96th |
Industry group Drugs | 61 out of 1,811 | 97th |
Industry Pharmaceutical Preparations | 41 out of 1,385 | 97th |
Source: SEC filing on April 10, 2019.
Dallas' colleagues
We found five more compensation records of executives who worked with Jayson D.A. Dallas at Aimmune Therapeutics in 2018.
2018
Douglas Sheehy
Aimmune Therapeutics
General Counsel
2018
Daniel Adelman
Aimmune Therapeutics
Chief Medical Officer
2018
Eric Bjerkholt
Aimmune Therapeutics
Chief Financial Officer
2018
Stephen Dilly
Aimmune Therapeutics
Chief Executive Officer
2018
Susan Barrowcliffe
Aimmune Therapeutics